Document Detail


Flecainide-induced JT prolongation, T wave inversion and ventricular tachycardia during treatment for symptomatic atrial fibrillation.
MedLine Citation:
PMID:  8077075     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Two hours after taking 100 mg of flecainide, a patient developed gastrointestinal complaints, dizziness and shortness of breath. The ECG demonstrated novel prolonged JT interval with negative T wave in the precordial leads. During admission, several attacks of non-sustained ventricular tachycardia occurred. The plasma drug concentration was 814 mg/l. Although the tachycardia was non-sustained, cardiovascular collapse developed. Serum electrolytes were normal and myocardial infarction was excluded. The patient is now free of symptoms without medications.
Authors:
S A Said; S T Somer; H A Oude Luttikhuis
Related Documents :
10822185 - Fetal arrhythmias.
18977665 - Late reoperations for fontan patients: state of the art invited review.
4025155 - Electrophysiologic effects of amrinone.
7002305 - Electrophysiologic management of recurrent ventricular tachycardia in acute and chronic...
21700755 - Effect of partial inhibition of fatty acid oxidation by trimetazidine on whole body ene...
22527755 - P-wave locking in the postventricular atrial refractory period of cardiac resynchroniza...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  International journal of cardiology     Volume:  44     ISSN:  0167-5273     ISO Abbreviation:  Int. J. Cardiol.     Publication Date:  1994 May 
Date Detail:
Created Date:  1994-10-06     Completed Date:  1994-10-06     Revised Date:  2006-07-12    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  IRELAND    
Other Details:
Languages:  eng     Pagination:  285-7     Citation Subset:  IM    
Affiliation:
Department of Cardiology, Streekziekenhuis Midden-Twente, Hengelo, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Atrial Fibrillation / drug therapy,  therapy*
Electric Countershock
Electrocardiography
Female
Flecainide / adverse effects*,  therapeutic use
Heart Conduction System / drug effects*
Humans
Tachycardia, Ventricular / chemically induced*
Chemical
Reg. No./Substance:
54143-55-4/Flecainide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Assessment of tricuspid regurgitation by Doppler color flow imaging: angiographic correlation.
Next Document:  Does passive leg raising increase cardiac performance? A study using Doppler echocardiography.